Adverse reactions such as upper respiratory tract infections, oral herpes, and tinea pedis may occur with the treatment of psoriasis with skuticizumab.
Skuticizumab inhibits the release of pro-inflammatory cytokines and chemokines and is usually used in the treatment of adult patients with moderate to severe plaque psoriasis. Adverse reactions such as respiratory infections such as rhinitis, oral herpes, tinea pedis, conjunctivitis, diarrhea, and urticaria may occur with the use of the drug.
When suffering from psoriasis, you should go to the hospital in a timely manner, under the guidance of the physician to carry out the relevant treatment, strictly comply with the doctor’s instructions to use the drug, allergic to the components of the product is prohibited, the use of drugs in the process of discomfort should be reported to the health care personnel in a timely manner and to take appropriate measures to deal with the problem, if you need to be used in conjunction with other medicines, you can consult a physician in advance.